Revive Therapeutics (RVVTF) Regulatory Update Archive.
April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as the rate...
Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...
American Chemical Society
May 2020.
Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...
Revive Therapeutics Announces Entry Into Phase III FDA Trial Using Glutathione Boosting Bucillamine.
Revive Therapeutics Announces U.S. FDA Recommendation to Proceed Directly Into A Phase 3 Confirmatory Clinical Trial
TORONTO, April 23, 2020 (GLOBE NEWSWIRE) --Revive Therapeutics Ltd.Ltd....
Latest article
Rick Rule Symposium – Conference Cheat Sheet
Natural Resource Investing Symposium - Presenter Guide
We've attended hundreds and hundreds of Investment Conferences (Barclay, JP Morgan, LD Micro, Piper Sandler, Roth, VRIC) since...
GeoVax (GOVX) Surges 256%, With 207 Million Shares Trading!
What an Entertaining Week!
..and it's only Thursday.
LIVE QUOTE
(MAY 18TH)
(MAY 21ST)
So Where Does That Leave us Today?
Yes, it was a pleasant surprise to see GeoVax...
Americore (AMCOF) Funding Launched. Looks Like Good Entry Point.
All Systems Go?
A recently completed Magnetometer survey sends a strong signal to investors that the company is advancing its project in a disciplined, data-driven...
